Organ-Tumor-on-a-Chip Market- Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Axosim Technologies LLC, Beonchip S. L., BioIVT LLC, Emulate Inc

Acknowledging the kind of traction gained by this market, Industry Data Analytics recently published a study report asserts the global Organ-Tumor-on-a-Chip Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 33.9% during the review period (2022 to 2027)

Organ-Tumor-on-a-Chip Market Overview

Despite massive efforts to understand cancer biology and create anticancer medicines, cancer remains one of the top causes of mortality. The key hurdles in cancer research are creating a functional tumour microenvironment in vitro and figuring out the best ways to screen anticancer medications in order to learn more about cancer and develop treatments. Tumor-on-a-chip is a small cell culture device that mimics the form and behaviour of tumour cells in vitro. Tumor-on-a-chip can be used to simulate tumour development and expansion, angiogenesis, and progression from early to advanced lesions involving EMT, tumour cell invasion, and metastasis.

Who are the Major Players in Organ-Tumor-on-a-Chip Market?

The global Organ-Tumor-on-a-Chip includes identification and analysis of the various market participants competing in the global market. Prominent competitors include Axosim Technologies LLC, Beonchip S. L., BioIVT LLC, Emulate Inc., InSphero AG, Mimetas B.V., Nortis, Inc., Organovo Holdings, Inc. And Others.

Industry News and Updates:

Emulate Announces Launch of Immune Cell Recruitment Application for the Colon Intestine-Chip to Aid in the Study of Inflammatory Bowel Disease

MAY 9, 2022-Emulate, Inc., a leading provider of next-generation in vitro models, today announced its new colon immune cell recruitment application, enabling the most human-relevant preclinical assessment of inflammatory bowel disease (IBD) drug candidates.

What are the major Applications, Types and Regions for Organ-Tumor-on-a-Chip Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Lung Tumor-on-a-chip


• Bone Marrow Tumor-on-a-chip


• Brain Tumor-on-a-chip


• Breast Tumor-on-a-chip


• Urinary System Tumor-on-a-chip


• Intestine Tumor-on-a-chip


• Liver Tumor-on-a-chip


• Others

By Application, it is segmented into

• Hospital


• Laboratory


• Others

Organ-Tumor-on-a-Chip Market Regional Analysis

North America dominated the organ-tumor-on-a-chip market in 2020 and is expected to continue to do so throughout the forecast period, owing to rising demand for organ-tumor-on-chips in drug screening, particularly in the United States, as well as an increase in the number of key market players and research centres in the region.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

What is our Organ-Tumor-on-a-Chip Market report scope?

Key Takeaways from this Organ-Tumor-on-a-Chip Report

• Evaluate Organ-Tumor-on-a-Chip market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Organ-Tumor-on-a-Chip market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

How do you conduct primary research interviews?

We use tools such as video conferences, telephone calls, face-to-face interviews, and questionnaires with key respondents.

What if the report I want is not listed in the repository of your reports?

IndustryDataAnalytics has a repository of reports on various industry verticals and not all of them have been listed on the website. Please contact our sales team with your requirements.

Who are the key players in Organ-Tumor-on-a-Chip Market?

Axosim Technologies LLC, Beonchip S. L., BioIVT LLC, Emulate Inc., InSphero AG, Mimetas B.V., Nortis, Inc., Organovo Holdings, Inc.

What regions does this Organ-Tumor-on-a-Chip Market report cover?

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What are the significant types of Organ-Tumor-on-a-Chip Market?

Lung Tumor-on-a-chip, Bone Marrow Tumor-on-a-chip, Brain Tumor-on-a-chip, Breast Tumor-on-a-chip, Urinary System Tumor-on-a-chip, Intestine Tumor-on-a-chip, Liver Tumor-on-a-chip

What are the major end-use applications of the Organ-Tumor-on-a-Chip Market?

Hospital, Laboratory, Others

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.